2025
Polycystic Kidney Disease in Children: The Current Status and the Next Horizon
Cadnapaphornchai M, Dell K, Gimpel C, Guay-Woodford L, Gulati A, Hartung E, Liebau M, Mallett A, Marlais M, Mekahli D, Piccirilli A, Seeman T, Tindal K, Winyard P. Polycystic Kidney Disease in Children: The Current Status and the Next Horizon. American Journal Of Kidney Diseases 2025 PMID: 40113156, DOI: 10.1053/j.ajkd.2025.01.022.Peer-Reviewed Original ResearchAutosomal recessive polycystic kidney diseaseAutosomal dominant polycystic kidney diseasePolycystic kidney diseaseKidney diseaseFetal lifePathogenic mechanismsUrinary concentrating defectProgressive chronic kidney diseaseRecessive polycystic kidney diseaseDominant polycystic kidney diseaseChronic kidney diseaseAdult-onset diseaseDiagnostic modalitiesConcentrating defectPortfolio of clinical trialsTherapeutic managementClinical trialsInherited disorderBurden of diseaseClinical assessmentKidney cystsTherapeutic targetCilia dysfunctionAge groupsDiseaseThe Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications—A Narrative Review
Mahabamunuge J, Sekula N, Lepore C, Kudrimoti M, Upadhyay A, Alshowaikh K, Li H, Seifer D, AlAshqar A. The Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications—A Narrative Review. Biomedicines 2025, 13: 709. PMID: 40149685, PMCID: PMC11940587, DOI: 10.3390/biomedicines13030709.Peer-Reviewed Original ResearchPolycystic ovary syndromeType 2 diabetes mellitusCardiometabolic morbidityIncreased cardiovascular riskDevelopment of hypertensionCardiovascular risk factorsNarrative reviewPotential clinical implicationsAndrogen excessEndothelial dysfunctionCardiovascular riskClinical conditionsPredisposed individualsTherapeutic strategiesAdipokine secretionRisk factorsInsulin resistanceCardiometabolic diseasesCardiovascular diseaseClinical implicationsMorbidityMellitusSyndromeMolecular mechanismsDiseaseEarly Release - Mycobacterium nebraskense Isolated from Patients in Connecticut and Oregon, USA - Volume 31, Number 3—March 2025 - Emerging Infectious Diseases journal - CDC
Metersky M, Losier A, Fraulino D, Warnock T, Varley C, Le A, Winthrop K, McArdle J, Shakir S, Khare R. Early Release - Mycobacterium nebraskense Isolated from Patients in Connecticut and Oregon, USA - Volume 31, Number 3—March 2025 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2025, 31: 507-515. PMID: 40023800, PMCID: PMC11878316, DOI: 10.3201/eid3103.240608.Peer-Reviewed Original ResearchConceptsNontuberculous mycobacterial pulmonary diseaseMycobacterial pulmonary diseaseAmerican Thoracic Society/Infectious Diseases Society of America criteriaAntimicrobial drug susceptibility testingPulmonary diseaseDrug susceptibility testingRefractory to treatmentClinically significant causeClarithromycin susceptibilitySusceptibility testingConnecticut patientsRespiratory secretionsPatientsNo symptomsOptimum treatmentSignificant causeInfectionHuman casesDiseaseTreatmentCDCClarithromycinCasesClinicM. nebraskensePericardial Disease: Contemporary Techniques and Management
Bae J, Saleh A, Hu J, Setaro J, Altin S. Pericardial Disease: Contemporary Techniques and Management. Current Treatment Options In Cardiovascular Medicine 2025, 27: 23. DOI: 10.1007/s11936-025-01081-7.Peer-Reviewed Original ResearchTreatment of recurrent pericarditisManagement of pericardial diseasesImmunosuppressive therapyRecurrent pericarditisTransthoracic echocardiographySignificant management challengeRefractory casesRecurrence ratePericardial diseaseTherapeutic optionsPharmacological therapyTherapeutic advancesClinical trialsTherapeutic approachesPoor visualizationDiagnostic precisionTherapyPatientsDiseaseDiagnostic techniquesSymptom burdenEvidence-basedPatient careTransthoracicEchocardiographyColorectal Neoplasia in Inflammatory Bowel Disease
Al Sulais E, AlAmeel T, Alenzi M, Shehab M, AlMutairdi A, Al-Bawardy B. Colorectal Neoplasia in Inflammatory Bowel Disease. Cancers 2025, 17: 665. PMID: 40002259, PMCID: PMC11853504, DOI: 10.3390/cancers17040665.Peer-Reviewed Original ResearchRisk of colonic neoplasiaColonic neoplasiaInflammatory bowel diseaseConcomitant primary sclerosing cholangitisRisk factorsMultiple risk factorsColorectal neoplasiaBowel diseaseHigh-risk featuresIncreased riskPrimary sclerosing cholangitisColonic Crohn's diseaseColonic dysplasiaDisease extentSclerosing cholangitisRiskCrohn's diseaseNeoplasiaUlcerative colitisDiseaseSurveillancePatientsColorectalEpidemiologyThe Complex Landscape of Updated Pneumococcal Conjugate Vaccines
Thindwa D, Shapiro E, Weinberger D. The Complex Landscape of Updated Pneumococcal Conjugate Vaccines. Open Forum Infectious Diseases 2025, 12: ofaf050. PMID: 39968305, PMCID: PMC11834978, DOI: 10.1093/ofid/ofaf050.Peer-Reviewed Original ResearchExercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing
Tarras E, Singh I, Kreiger J, Joseph P. Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing. Journal Of Clinical Medicine 2025, 14: 804. PMID: 39941482, PMCID: PMC11818252, DOI: 10.3390/jcm14030804.Peer-Reviewed Original ResearchInvasive cardiopulmonary exercise testingPulmonary arterial hypertensionCardiopulmonary exercise testingArterial hypertensionAssociated with pulmonary vascular remodelingExercise testRight heart failureExercise pulmonary hypertensionPulmonary vascular remodelingPulmonary hypertensionProgressive diseasePulmonary vasculatureTherapeutic optionsExercise pathophysiologyHigh morbidityHeart failureEarly diagnosisVascular remodelingTherapeutic approachesPersonalized treatmentHypertensionDisease subtypesDiagnosisSkeletal muscleDiseaseCCL17 Influences Borrelia burgdorferi Infection in the Heart
Tang X, Yu Q, Cui Y, Hart T, Rivas-Giorgi F, Calloway K, Mohapatra A, Fikrig E. CCL17 Influences Borrelia burgdorferi Infection in the Heart. The Journal Of Infectious Diseases 2025, jiaf011. PMID: 39777514, DOI: 10.1093/infdis/jiaf011.Peer-Reviewed Original ResearchSerum levels of proinflammatory cytokinesLevels of proinflammatory cytokinesVector-borne pathogensB. burgdorferiReduce pathogen loadImmune alterationsMacrophage infiltrationProinflammatory cytokinesCCL17B. burgdorferi infectionIxodes ticksPathogen loadControl animalsChemokinesBorrelia burgdorferiInfectious diseasesInfectionDiverse illnessesKnockoutLyme diseaseDiseaseGrover disease shows type 2 immune activation and improves with dupilumab
Murphy M, Junejo M, Rufin O, Cohen J, Nelson C, Damsky W. Grover disease shows type 2 immune activation and improves with dupilumab. British Journal Of Dermatology 2025, ljaf005. PMID: 39775460, DOI: 10.1093/bjd/ljaf005.Peer-Reviewed Original ResearchThe Art of Dermatology: Lessons Learned from Master Morphologist, Dr. Irwin Braverman
Eisenstein A, Johnston M, Laird M, Perkins S, Siegel J, Watsky K. The Art of Dermatology: Lessons Learned from Master Morphologist, Dr. Irwin Braverman. Clinics In Dermatology 2025 PMID: 39778634, DOI: 10.1016/j.clindermatol.2024.12.012.Peer-Reviewed Original ResearchThe evolving understanding of systemic mechanisms in organ-specific IgA nephropathy: a focus on gut-kidney crosstalk
Wang X, Zhou X, Qiao X, Falchi M, Liu J, Zhang H. The evolving understanding of systemic mechanisms in organ-specific IgA nephropathy: a focus on gut-kidney crosstalk. Theranostics 2025, 15: 656-681. PMID: 39744688, PMCID: PMC11671385, DOI: 10.7150/thno.104631.Peer-Reviewed Original ResearchConceptsGut-kidney crosstalkExploration of gut microbiotaGut microbiotaKidney diseaseMechanism of IgANIntestinal microbiomeSignaling pathwayIgA nephropathyInter-organ crosstalkEfficient therapeutic strategiesPrognosis of patientsProgression of IgANElaborate mechanismsTherapeutic strategiesIgAN pathogenesisIgANCrosstalkMicrobiomeMicrobiotaMultiple organsKidneyProbioticsNephropathyDiseaseMechanism
2024
Trigeminal neuralgia within the disease course of MS: Diagnostic and therapeutic implications from a multicenter cohort.
Laakso S, Oh J, Raufdeen F, Jones A, Reiskanen H, Feb K, Levit E, Solomon A. Trigeminal neuralgia within the disease course of MS: Diagnostic and therapeutic implications from a multicenter cohort. Multiple Sclerosis Journal 2024, 13524585241309257. PMID: 39727322, DOI: 10.1177/13524585241309257.Peer-Reviewed Original ResearchTrigeminal neuralgiaClinical relapseMultiple sclerosisActive diseaseEvidence of active diseaseDisease course of MSAssociated with multiple sclerosisCourse of MSDemyelination symptomsMulticenter cohortDisease courseTherapeutic decisionsTherapeutic implicationsMS diagnosisNeuralgiaRelapseDiseaseOnsetSclerosisAcute Decompensated Valvular Disease in the Intensive Care Unit
Miller P, Senman B, Gage A, Carnicelli A, Jacobs M, Rali A, Senussi M, Bhatt A, Hollenberg S, Kini A, Menon V, Grubb K, Morrow D, Section A. Acute Decompensated Valvular Disease in the Intensive Care Unit. JACC Advances 2024, 3: 101402. PMID: 39735779, PMCID: PMC11681797, DOI: 10.1016/j.jacadv.2024.101402.Peer-Reviewed Original ResearchIntensive care unitCardiac intensive care unitValvular diseaseCritically ill patientsCare unitIll patientsPrimary cardiac disorderMultidisciplinary heart teamModern cardiac intensive care unitPercutaneous interventional therapyDefinitive treatmentSurgical riskClinical presentationSocietal guidelinesHeart teamValvular disordersTreatment optionsInterventional therapyCardiac disordersDiseasePatientsTreatmentDisordersSurgeryTherapyCutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatment
Damsky W, King B. Cutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatment. Clinics In Dermatology 2024 PMID: 39694198, DOI: 10.1016/j.clindermatol.2024.12.017.Peer-Reviewed Original ResearchCutaneous manifestations of sarcoidosisManifestation of sarcoidosisMultisystem inflammatory disorderFDA-approved therapiesLevel of evidenceCutaneous involvementCutaneous sarcoidosisCutaneous manifestationsHistopathological findingsInflammatory disordersSarcoidosisLymphatic systemTreatment approachesDisease pathogenesisRecommended evaluationDiseasePrednisoneCorticotropinTherapyPatientsMultisystemLungPathogenesisNail Disorders as clues to systemic disease
Rowe E, Zubek A. Nail Disorders as clues to systemic disease. Clinics In Dermatology 2024 PMID: 39694199, DOI: 10.1016/j.clindermatol.2024.12.013.Peer-Reviewed Original ResearchMixed and undifferentiated autoimmune connective tissue diseases
Vesely M. Mixed and undifferentiated autoimmune connective tissue diseases. Clinics In Dermatology 2024 PMID: 39681290, DOI: 10.1016/j.clindermatol.2024.12.011.Peer-Reviewed Original ResearchConnective tissue diseaseTissue diseaseCutaneous manifestationsUndifferentiated connective tissue diseaseAutoimmune connective tissue diseaseEra of molecular diagnosticsSigns of systemic diseaseUrticarial vasculitisSystemic complicationsSjogren's syndromeClinical entityDescription of patientsSystemic diseaseClinical observationsDisease characterizationMolecular diagnosticsDiseasePatientsVasculitisBiodistribution of Polymeric Nanoparticles following in utero Delivery to a Nonhuman Primate
Eaton D, Lynn A, Surprenant J, Deschenes E, Guerra M, Rivero R, Yung N, O'Connor M, Glazer P, Bahtiyar M, Saltzman W, Stitelman D. Biodistribution of Polymeric Nanoparticles following in utero Delivery to a Nonhuman Primate. Biomedicine Hub 2024, 10: 543138. PMID: 39845408, PMCID: PMC11753793, DOI: 10.1159/000543138.Peer-Reviewed Original ResearchMonogenic diseasesNon-human primatesBiodistribution of polymeric nanoparticlesPreclinical mouse modelsStem cell populationFetal liverFetal malesSystemic deliveryFetal bonesAccumulation of NPIn-uteroMid-gestationNP accumulationBiodistribution studiesPolymeric NPsTherapeutic accessCell populationsMaternal tissuesZone of proliferationPolymeric nanoparticlesDiseaseBirthMiceDeliveryBiodistributionUnlocking the potential of miRNAs in detecting pulmonary tuberculosis: prospects and pitfalls
Arya R, Kumar S, Vinetz J, Kim J, Chaurasia R. Unlocking the potential of miRNAs in detecting pulmonary tuberculosis: prospects and pitfalls. Expert Reviews In Molecular Medicine 2024, 26: e32. PMID: 39639643, PMCID: PMC11629464, DOI: 10.1017/erm.2024.29.Peer-Reviewed Original ResearchConceptsDisease stageHIV co-infectionAnti-TB therapyPotential of miRNAsInfectious diseasesPulmonary TBPulmonary tuberculosisActive TBFalse-positive outcomesTB diagnosticsDisease progressionLack of specificityPrognostic signatureCo-infectionLethal infectious diseaseDeadliest infectious diseasesPoint-of-care testingTuberculosisDiagnostic biomarkersStandard protocolDiseaseBiomarkersGene expressionNon-invasiveRegulatory rolemRNA Vaccines Against Tick‐borne Diseases
Arora G, Fikrig E. mRNA Vaccines Against Tick‐borne Diseases. 2024, 285-301. DOI: 10.1002/9783527838394.ch10.Peer-Reviewed Original ResearchTick-borne diseasesMRNA vaccinesIxodes scapularis ticksCrimean-Congo hemorrhagic feverEffective memory responsesVector-borne diseasesIncreasing cost of developmentPowassan virusModified mRNA vaccineMRNA-based vaccinesTicksVaccine platformTurnover timeLipid nanoparticlesMemory responsesClinical trialsImmune systemEffective vaccineMultiple antigensPathogensSpreading virusArthropodsVaccineDiseaseHemorrhagic feverAnalysis of Online Crowdfunding Among Patients Pursuing Metabolic and Bariatric Surgery in the United States
Hamid S, Graetz E, Bakkila B, Chao G, Zolfaghari E, Schultz K, Chetty A, Trabilsy M, Schneider E, Gibbs K. Analysis of Online Crowdfunding Among Patients Pursuing Metabolic and Bariatric Surgery in the United States. Obesity Surgery 2024, 35: 170-180. PMID: 39633092, DOI: 10.1007/s11695-024-07605-7.Peer-Reviewed Original ResearchBariatric surgeryNon-medical expensesRoux-en-Y gastric bypassNon-surgical attemptsRoux-en-YObesity-associated diseasesSleeve gastrectomyGastric bypassBiliopancreatic diversionDuodenal switchAssessed associationsLogistic regressionSurgeryIQRPatientsMedianDiseaseLost wagesHealth-related diseasesUnmet financial needs
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply